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Endoscopic management of procedure-related bleeding
Louis M. Wong Kee Song, Todd H. Baron*
a b s t r a c t
Bleeding is a common adverse event following invasive endoscopic procedures within the gastrointestinal tract. In a recent lexicon of adverse events
following endoscopic procedures, severity of bleeding was deﬁned as mild, moderate, and severe. These deﬁnitions are based on need for hospitalization,
transfusion, and subsequent interventions. Therapy for procedure-related bleeding includes hemodynamic stabilization, transfusion of blood products,
reversal of coagulopathy (if present), and endoscopic, radiologic, and/or surgical interventions. In this article, the approach to procedurally induced
bleeding will be reviewed, with an emphasis on endoscopic intervention.
Copyright  2012, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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Therapeutic endoscopy has become increasingly complex and
invasive. Most endoscopic interventions breach vascular structures
coursing through the wall of the gastrointestinal (GI) lumen and
carry a risk of immediate or delayed bleeding as these vessels are
severed. Other interventions can produce cautery-induced ulcers
which may then erode into vessels and cause delayed bleeding.
Post-procedural bleeding can range from mild and easily
treatable to severe and life-threatening hemorrhage, requiring
additional endoscopic, angiographic, or surgical interventions.1
Fortunately, procedure-related bleeding in most instances can be
controlled endoscopically (Table 1). Medical stabilization and
supportive therapy are also paramount to a successful outcome. In
this article, the management of procedure-related bleeding will be
discussed, with an emphasis on endoscopic therapy.Immediate versus delayed bleeding
Procedure-related bleeding can be immediate (intra-procedural)
or delayed (post-procedural). Immediate bleeding may or may not
require therapy.Most intra-procedural bleeding is self-limited, does
not interfere with continuation of the procedure, and resolves
without interventionby the time theprocedure is completed.On the
other hand, delayed bleeding is usually clinically signiﬁcant. The
delay fromonset of recognition of bleedinguntil the time thepatient
reaches medical care can result in volume depletion, hypotension,
and exacerbation of underlying comorbidities, such as ischemic
heart disease. Thus, the approach to bleeding is dependent onDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
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separately.Immediate bleeding
Intra-procedural bleeding is only considered an adverse event if it
causes the procedure to be aborted or alters proceduralmanagement.1
For example, post-sphincterotomy bleedingwhich prevents complete
ductal clearance (e.g., a temporary biliary stent is placed) during
Endoscopic retrograde cholangiopancreatography (ERCP) and
extraction of a bile duct stone is considered an adverse event even if
the patient does clinically well without need for transfusion, since an
additional procedure will be required for subsequent stone removal.
On the other hand, bleeding which does not prevent procedural
completion and does not alter management (no need for blood
transfusion and hospital admission) is not considered an adverse
event. Indeed, intra-procedural bleeding is expected in some proce-
dures, such as endoscopic submucosal dissection (ESD), which is
readily managed usingmonopolar grasping forceps for coagulation of
small blood vessels. Site-speciﬁc intra-procedural bleeding scenarios
that are commonly encountered and their management will be dis-
cussed below.Delayed bleeding
Clinically signiﬁcant delayed bleeding is deﬁned by hematem-
esis, melena, and/or hematochezia, with a drop in hemoglobin
2 g/dL.10 First Street S.W., Rochester, MN, USA.
on. Published by Elsevier. All rights reserved.
Table 1 Endoscopic Hemostasis Techniques
Injection therapy
Epinephrine
Sclerosants
Fibrin glue
Coagulation
Grasping forceps
Bipolar electrocoagulation probes
Heater probe
Clips
Through-the-scope clips
Over-the-scope clips
Endoscopic band ligation
Endoscopic loop ligation
Balloon tamponade
Self-expandable metal stent placement
Endoscopic ultrasound guided injection therapy
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It is important to emphasize that medical stabilization is of
utmost importance before endoscopic therapy is undertaken for
delayed bleeding. This initial approach is similar to non-procedural
related GI bleeding (e.g., variceal, peptic ulcer, diverticular).2
Measures to stabilize the patient include adequate volume resus-
citationwhile avoiding volume overexpansion, transfusion of blood
products as appropriate (target hemoglobin levels of 8–9 g/dL in
most patients), and reversal of coagulopathy (international
normalized ratio <2.5). An increasing number of patients (e.g.,
those with coronary stents) are receiving antithrombotic agents
(anticoagulants and antiplatelet agents), which may require
reversal agents, administration of fresh frozen plasma, or platelet
transfusion, although this should be done in conjunction with the
advice of a cardiologist or internist so that fatal thrombotic events
(such as occlusion of coronary stents) do not occur.3 Patients with
coagulopathy due to liver disease and those with signiﬁcant
thrombocytopenia (platelet count <50,000) from any cause may
beneﬁt from transfusion of fresh frozen plasma and platelets,
respectively.
Depending on the severity of bleeding, admission to an inten-
sive care unit may be indicated, especially in elderly patients and
those with severe underlying medical conditions (e.g., coronary
artery disease). The procedure can then be performed at the
bedside with critical care support rather than transporting theTable 2 Grading Severity for Post-procedural Bleeding
Consequence
Procedure aborted (or not completed) because of an adverse event
Unplanned anesthesia/ventilation support due to bleeding,
(i.e., endotracheal intubation during moderate (conscious) sedation
Post-procedural medical consultation
Unplanned hospital admission or prolongation of hospital stay for 3 nights
Unplanned admission or prolongation for 4–10 nights
Unplanned admission or prolongation for >10 nights
ICU admission for 1 night
ICU admission >1 night
Transfusion
Repeat endoscopy for control of bleeding
Interventional radiology for control of bleeding
Surgery for control of bleeding
Permanent disability (example, bleeding induced stroke or myocardial infarction)
Death
Modiﬁed, with permission, from Cotton et al.1patient to the endoscopy suite. In patients with active post-
procedural upper GI bleeding (e.g., repeated hematemesis),
consideration should be made for endotracheal intubation for
airway protection. Adequate sedation is important and may also
require anesthesia assistance.
In patients with suspected lower GI bleeding (e.g., recent colon
polypectomy), rapid colonic purge administered orally or via
a nasogastric tube4 can be performed in those who require urgent
colonoscopy based on clinical presentation and severity of
bleeding. Standard colonic preparation is adequate in an otherwise
stable patient, followed by colonoscopy the following day.
The decision to perform and timing of colonoscopy in patients
with post-polypectomy bleeding is not standardized. As most post-
polypectomy bleeding stops without intervention, particularly
following resection of small polyps, one approach is to administer
a bowel preparation and follow the stool pattern. If the patient
presented with clinically mild bleeding, has few comorbid medial
illnesses, remains hemodynamically stable and the bloody efﬂuent
clears with preparation, withholding colonoscopy may be
a reasonable option, and one could choose to simply monitor the
patient. The other option is colonoscopy within 24 hours for all
patients, followed by early discharge in otherwise healthy patients
if there are no high-risk stigmata of recent hemorrhage or active
bleeding, and when deﬁnitive endoscopic therapy is provided. This
latter approach is similar to that used for peptic ulcer bleeding.5Classiﬁcation of severity of bleeding
Until recently, assessment of the severity of bleeding was not
standardized. Standardization of the grade of severity for bleeding
is important for several reasons. First, it allows meaningful
comparative outcomes between different techniques and among
different centers. Second, it allows proper education of the patient
so that an informed consent can be made. Finally, it is believed that
some health-care systems third-party payers will rely on such
information to determine reimbursement in the future.
In an initiative led by Dr Peter Cotton, a working group proposed
a lexiconof adverse events.1 In this lexicon, the severity of bleeding is
deﬁned the same regardless of the type of procedure. For example,
post-polypectomy colonic bleeding is graded the same as post-
sphincterotomy bleeding.
There are four grades of bleeding severity: mild, moderate,
severe, and fatal (Table 2). The severity is based on effect on the
procedure, need for hospitalization, blood transfusion, intensiveSeverity grade
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Gastrointestinal Intervention 2012 1(1), 43–52 45care unit stay, and additional procedures (endoscopic, radiologic,
and surgical). Death due to bleeding is categorized as fatal.
If initial endoscopic therapy is successful but bleeding recurs,
additional endoscopic therapymay be useful. Although there are no
data to support the beneﬁt of additional endoscopic therapy, data
on endoscopic therapy for peptic ulcer bleeding supports this
approach.6 If one form of endoscopic therapy has been tried, the
same or alternative endoscopic therapies can be employed. For
refractory bleeding, interventional radiologic approaches with
embolization should be considered before surgery. Surgery may be
more appropriate when otherwise indicated (e.g., malignant inva-
sive colorectal polyp).
Hemostatic modalities
Endoscopic
A variety of endoscopic hemostatic approaches can be used to
treat bleeding in any areawithin the GI tract (Table 1). The selection
of a particular device(s) is inﬂuenced by location and features of the
lesion, operator preference, and device availability.Injection therapies
A dilute epinephrine solution (1:10,000) is typically used to
control rapid intra-procedural bleeding which obscures endoscopic
visualization. A ceiling volume has not been established, but as
much as 30 mL of dilute epinephrine can be injected in a single
treatment session. An advantage of epinephrine injection is theﬁeld
effect achieved via vasoconstriction and tamponade, such that
precise localization of the bleeding site is not mandatory and the
injection can be applied with relative ease. Since the effects ofFig. 1. (A) Active bleeding during endoscopic submucosal dissection (ESD); (B) submucosa
Coagrasper (arrow); (D) appearance of coagulated vessel (arrow).epinephrine injection are short-lived, the use of adjunctive thermal
(e.g., bipolar coagulation) or mechanical (e.g., clips and bands)
modalities is recommended, when feasible, to secure hemostasis.
Absorption of epinephrine into the bloodstream can lead to tachy-
cardia and hypertension, and though rarely clinically signiﬁcant,
large volume injection should be avoided in patients with under-
lying coronary artery disease and/or tachyarrhythmias.
Although effective, the injection of sclerosants, such as absolute
alcohol, ethanolamine, polidocanol, and sodium tetradecyl sulfate,
is generally avoided for non-variceal lesions due to lesion extension
and the unpredictable depth of tissue injury caused by these agents.
Similarly, the injection of cyanoacrylate (glue) is rarely used for
post-procedural bleeding, except for recurrent gastric variceal
hemorrhage.7Thermal therapies
As mentioned above, intra-procedural bleeding commonly
occurs during ESD as submucosal vessels are severed. Devices
speciﬁcally used to control such bleeding include the monopolar
coagulation forceps with short, serrated metal jaws to grasp, tent,
and coagulate the vessels (Coagrasper; Olympus Inc., Center
Valley, PA, USA) (Fig. 1). This device has the potential to treat other
non-variceal lesions in which precise vessels can be grasped.
Contact thermalprobes includebipolarelectrocoagulationprobes
(e.g., Gold Probe; Boston Scientiﬁc Inc., Natick, MA, USA) and the
heater probe (Olympus Inc., Tokyo, Japan). Non-contact thermal
probes include argon plasma coagulation (APC; ERBE USA Inc., Mar-
ietta, GA, USA; Beamer, ConMed Endoscopic Technologies, Utica, NY,
USA). Although thermal probes enable treatment of lesions that are
either en face or tangential in location, a disadvantage of coagulation
therapy is tissue injury which, when compounded by tissue damagel bleeding vessel identiﬁed (arrow); (C) bleeding vessel grasped and coagulated with
Louis M. Wong Kee Song and Todd H. Baron / Endotherapy of procedure-related bleeding46already caused byprior therapy (e.g., hot snare resection), can lead to
perforation. In addition, the coaptation pressure applied by contact
thermal probes can lead to perforation as well. Inadvertent probe–
tissue contact during APC may dissect into tissue causing localized
pneumatosis, although this is rarely of clinical consequence.Mechanical hemostasis
Endoscopic clip placement is attractive for procedure-related
bleeding as it does not extend tissue injury. Several through-the-
scope (TTS) clips are available for use (Quickclip2, Olympus Inc.;
Resolution Clip, Boston Scientiﬁc Inc.; Instinct Endoscopic Hemo-
clip, Cook Endoscopy, Winston–Salem, NC, USA). The goal is to
place the clip directly onto the visible vessel or surrounding tissue,
which stops the ﬂow of feeding vessels, and multiple clips are often
required to secure hemostasis.8 However, disadvantages of clip
placement during intra-procedural bleeding include interference
with further dissection or resection, use of adjunctive tissue abla-
tion measures, and coagulation hemostatic methods. The long-
term clip retention rate is unknown but can occur and interfere
with follow-up endoscopic surveillance of neoplastic lesions.9
These clips are also difﬁcult to use with side-viewing endoscopes
because of the angulation through which they exit the endoscope.
Recently, an over-the-scope clip (OTSC; Ovesco Endoscopy AG,
Tuebingen, Germany) has become available. The setup and
deployment are similar to that of a variceal band ligator. The
advantage of this device is that it can grasp a much wider area and
larger volume of tissue than TTS clips. The device has been used
primarily for closure of perforations, but also shown to be effective
for control of post-polypectomy bleeding (Fig. 2).10 The rate of OTSC
retention long term is unknown but presumably occurs more
commonly than with TTS clips.
Although there are little data to support endoscopic band ligation
(EBL) for treatment of immediate bleeding other than esophageal
varices, they are theoretically useful for this purpose and have been
used to treat various non-variceal bleeding lesions.11–14 However,
they can only be used with short-length forward-viewing endo-
scopes because a cap is required and the length of the tripwire
(string) is limited. The cap may interfere with endoscopic visualiza-
tion, particularly in a bloodyﬁeld, and thedeployment string through
the working channel impairs suction capability. In addition, areas of
deep resection or induration (e.g., delayed post-polypectomy ulcer
bleed) might not be amenable to EBL.
One commercially available detachable snare that constricts and
ligates tissue (PolyLoop, formerly Endoloop, Olympus Inc.) is mostFig. 2. (A) Delayed bleeding from endoscopic mucosal resection (EMR)-induced duodenaloften used for prevention of bleeding during resection of large
pedunculated polyps with thick stalks. The detachable loop can be
used to treat bleeding after endoscopic resection of pedunculated
polyps, but residual stalk at the base of the polyp must be present
for the loop to hold.Hemostatic sprays
Chitosan- and mineral-based hemostatic granules or powders
are integrated in ﬁrst-aid kits used by the military to treat external
bleeding from combat wounds. The non-contact spray delivery of
similar agents during endoscopy has several advantages, including
ease of use, non-requirement for precise targeting, access to lesions
at difﬁcult locations (e.g., gastric lesser curve), and ability to rapidly
treat a large surface area.12
A dedicated device has received regulatory clearance in some
countries for endoscopic delivery of TC-325, a proprietary, inorganic,
absorbent powder which rapidly concentrates clotting factors at the
treated site to form an adherent coagulum (Hemospray, Cook
Endoscopy). Another hemostatic agent used off-label for endoscopic
hemostasis is the plant-derived Ankaferd Blood Stopper (Ankaferd
Health Products Ltd., Istanbul, Turkey), which forms a protein mesh-
work for rapid anchoring of erythrocytes without signiﬁcantly inter-
fering with individual coagulation factors or platelets.15
The potential for hemostatic sprays is in the treatment of
oozing-type bleeding.13 Based on their mechanism of action, they
may be of limited value in the absence of active bleeding (e.g., non-
bleeding visible vessel), or when bleeding is torrential leading to
a rapid “wash away” effect of the hemostatic agent by blood ﬂow.
Cryogenic sprays (liquid nitrogen or CO2) are used primarily for
mucosal ablation (e.g., Barrett’s esophagus) and, to a lesser extent, for
treatment of chronic hemorrhage caused by gastric antral vascular
ectasia or radiation proctopathy. However, cryotherapy is unlikely to
be used in most settings of post-procedural hemorrhage as it aggra-
vates bleeding in the immediate thawing period from mucosal
friability.Endoscopic ultrasound-guided hemostasis
Endoscopic ultrasound-guided therapy can be used in centers
where this expertise is available and other treatment options have
failed. The culprit vessel is identiﬁed and targeted injection per-
formed under Doppler control using a standard ﬁne needle aspi-
ration (FNA) needle.14 A variety of injectants have been deliveredulcer with visible vessel (arrow); (B) Closure of ulcer base with over-the-scope clip.
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polidocanol, and thrombin.15
Radiologic
Percutaneous intervention consists of selective16–18 or super-
selective17 angiographic identiﬁcation and embolization of the
feeding vessel(s) causing bleeding. While it is preferable that the
lesion is actively bleeding so that vessels(s) can be precisely iden-
tiﬁed, embolization can still be performed based on knowledge of
the endoscopic site and the vascular distribution to the area (e.g.,
gastroduodenal artery for bleeding duodenal ulcer). In situations
where endoscopic intervention was unsuccessful, placement of
endoscopic clips in an around the lesion can aid the interventional
radiologist to more selectively target the vascular territory of the
bleeding site for embolization.
Surgical
At institutions where endoscopists and interventional radiolo-
gists are readily available, surgery is considered a last resort for
management of procedure-induced bleeding that cannot be
controlled by endoscopic or radiologic means. Emergent salvage
surgery is rarely needed to prevent death from exsanguination and
carries a worse outcome than elective surgery. Ideal lesions for
surgical management include small bowel lesions where the area of
bleeding can readily be identiﬁed and resected, and colonic (non
rectal) lesions that are localized, and if proven malignant, would
otherwise be best managed surgically. When resection cannot be
undertaken (e.g., duodenal bleeding), surgical management
consists of duodenotomy and local hemostasis.
Speciﬁc conditions
Esophageal varices
Immediate bleeding rarely occurs from band ligation of esoph-
ageal varices and may be due to variceal avulsion during suction of
the varix into the cap followed by a misﬁred band or by band
slippage after initial successful deployment (Fig. 3), particularly
when targeting residual varices amid a scarred esophagus from
prior EBL.19 Treatment may consist of a repeat attempt at band
ligation, or injection of sclerosant or cyanoacrylate. The use of
a detachable loop, with or without glue injection, has also been
reported, although it may be technically difﬁcult to entrap smaller
varices with surrounding scarring.18,20,21 The experience regarding
the use of hemostatic sprays is limited in this setting.
The prevalence of clinically signiﬁcant delayed bleeding from
post-EBL ulcers was 2.74% (23 episodes among 837 EBL) in one
study.21 In conjunctionwith octreotide infusion and a proton pump
inhibitor, endoscopic treatment options include EBL and clip
placement (Fig. 4), although ulcer induration may hinder their
efﬁcacy. The successful use of cyanoacrylate injection has been
reported, as well as esophageal balloon tamponade and emergent
transjugular intrahepatic portosystemic shunts for uncontrolled
andmassive bleeding with hemodynamic instability. An alternative
option to balloon tamponade is placement of a fully covered,
removable esophageal self-expandable metal stent (SEMS), and the
successful use of SEMS for EBL-induced ulcer bleeding has also
been described.23 Recently, a SEMS designed for esophageal vari-
ceal tamponade and atraumatic removability (SX-Ella Danis stent;
Ella-CS, Hradec Kralove, Czech Republic) was shown to be effective
for the management of esophageal variceal bleeding refractory to
conventional therapies,24,25 and should also be effective for post-
EBL ulcer bleeding.Gastric varices
Endoscopic glue injection is the preferred treatmentmodality for
gastric variceal bleeding since sclerotherapy and EBL are associated
with high re-bleeding rates.26 Furthermore, post-EBL ulcer bleeding
can be massive and fatal due to the ulcer size overlying the gastric
varix.27 Intra-procedural and delayed hemorrhage from glue injec-
tion occurs typically at the site of the needle puncture. Bleeding is
generally controlled with additional injection of glue in the varix.
When procedure-related bleeding is uncontrollable during endos-
copy, treatment options include emergent transjugular intrahepatic
portosystemic shunts or balloon tamponade using a large capacity
gastric balloon (e.g., Linton–Nachlas tube).
Endoscopic mucosal resection and ESD
Procedure-related bleeding is most often associated with poly-
pectomy, and post-polypectomy colonic bleeding accounts for 2–6%
of acute lower GI bleeding.28,29 Immediate bleeding during ESD is
typically managed with the coagulation grasping forceps
(Coagrasper), as described above. Epinephrine injection is used
initially for immediate severe bleeding that interferes with visu-
alization during standard snare polypectomy or endoscopic
mucosal resection (EMR) techniques, which include cap-assisted
EMR, band-assisted EMR, and piecemeal polypectomy with or
without submucosal ﬂuid lift. Control of bleeding following
epinephrine injection enables completion polypectomy before use
of additional techniques, such as clips or thermal coagulation, for
deﬁnitive hemostasis. Of note, however, placement of endoclips in
the midst of a polypectomy procedure may interfere with subse-
quent resection and completion. When feasible, clip placement is
preferable as it does not add to tissue injury, and risk of perforation
is likely less compared to thermal modalities (Fig. 5).
In most instances, delayed bleeding from EMR and ESD can be
treated successfully via endoscopic means. As noted above, clip
placement is recommended, with or without epinephrine injection,
although this may not be feasible in the setting of an indurated
ulcer base (Fig. 6). The latter may be more conducive to a contact
thermal probe and offers some protection to perforation.
Another option for closure of EMR or ESD bleeding defects that
arewide is the clip-loop technique. This has been used in treatment
of peptic ulcer bleeding22,30 and consists of placing multiple clips at
the periphery of the lesion. A detachable snare is then used to bring
all the clips together for approximation of the defect. Hemostatic
sprays are an attractive alternative for post-EMR or ESD bleeding,
although data on long-term efﬁcacy and safety are not available.
Peptic ulcer bleeding
Procedure-related bleeding may occur during attempted endo-
scopic therapy of a peptic ulcer with high-risk stigmata of recent
hemorrhage, such as during coaptive coagulation of a non-bleeding
visible vessel or when removing a densely adherent clot overlying
an exposed vessel. Such bleeding can be dramatic. Initial therapy
consists of epinephrine injection, followed by attempted clip
placement or contact thermal coagulation as appropriate. The efﬁ-
cacy of hemostatic sprays in this setting has yet to be determined.
If massive uncontrollable bleeding occurs, especially when arising
from the posterior duodenal bulb, immediate angiography or
surgery is indicated.
Post-sphincterotomy bleeding
Endoscopicmanagement of post-sphincterotomy bleeding differs
from other types of endoscopic bleeding because the use of a side-
Fig. 3. (A) Initial band ligation of bleeding varix; (B) partial slippage of band; (C) complete slippage of band; (D) active bleeding immediately following band slippage; (E) successful
repeat band ligation of bleeding varix.
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zation of the papilla.31,32 TTS clips have been used to control post-
sphincterotomy bleeding (Fig. 7),33 although they tend to function
poorly through the duodenoscope. Cap-ﬁtted devices (e.g., EBL
andOTSC)arenot compatiblewithaduodenoscope. Injection therapyis easily administered, although a needle designed to work through
a side-viewing endoscope (Carr–Locke injection needle; US Endos-
copy, Mentor, OH, USA) functions better than standard injection
needles with a plastic sheath, which becomes kinked by the elevator
of the duodenoscope preventing the needle from exiting the sheath.
Fig. 4. (A) Post-banding ulcer with active bleeding; (B) hemostasis achieved with endoscopic clips (arrow). Other non-bleeding post-banding ulcers seen (asterisk).
Gastrointestinal Intervention 2012 1(1), 43–52 49Similar to the treatment of peptic ulcer bleeding, 10F contact
coagulation probes are preferable to 7F probes, although the 7F
probe is easier to pass through the duodenoscope and to bring into
position using the elevator.
Tamponade of post-sphincterotomy bleeding has been reported
using compliant stone retrieval balloons and rigid dilating balloons.
More recently, removable covered biliary SEMS have been used to
treat post-sphincterotomy bleeding.34,35
Miscellaneous
Dilation-related bleeding using balloon or polyvinyl dilators is
typically self-limited and requires no therapy. Instances of ongoing
hemorrhage despite several minutes of observation are usually
managed with clip closure of the focal site(s) of bleeding, with or
without epinephrine injection.
Clinically signiﬁcant intra-procedural bleeding following percu-
taneous endoscopic gastrostomy (PEG) is uncommon but can occur
if a vessel is punctured during passage of the trocar through the
abdominal wall, as occurs following radiologic percutaneous gas-
trostomy.36 Pseudoaneurysm formation can occur.18 Endoscopic
therapy can be attempted although transmural compression, and
tamponade of the bleeding vessel can usually e achieved by securing
the external bumper at the skin against the internal bumper of the
feeding tube. Delayed bleeding can also occur from ulcers devel-
oping beneath the internal bumper that result from excessive
traction on the PEG tube. Thus, it is important to loosen the external
bumper and advance the PEG tube inward so that endoscopic
inspection of themucosa compressed by the internal bumper can be
achieved (Fig. 8).Fig. 5. (A) Immediate post-polypectomy rectal bleedinDirect percutaneous endoscopic jejunostomy is performed less
frequently than PEG placement, although it can also cause bleeding,
which may occur after traction removal of initially placed tubes that
have an internal disk bumper.37 Endoscopic therapy can be under-
taken to identify an intraluminal bleeding site; this may require use
of balloon enteroscopes. Unlike PEG placement, mesenteric vessels
may be injured during initial direct percutaneous endoscopic jeju-
nostomy placement, which are not amenable to endoscopic
therapy.15
Transmural (transgastric, transduodenal) drainage of pancreatic
ﬂuid collections (pseudocysts, abscess, and necrosis) may result in
bleeding as a result of puncture of a blood vessel. Such blood vessels
may be coursing through the wall of the organ and can be arterial or
venous (intervening varices seen with splenic vein thrombosis).
Additional bleeding can be due to vessels coursingwithin the cavity,
such as the splenic artery. Finally, during direct endoscopic
necrosectomy, vessels within the cavity, including branches of the
portal vein, can be injured during debridement.38 Management of
bleeding caused by vessels puncturedwithin the gastric or duodenal
wall can be managed by endoscopic injection of epinephrine in
combination with coagulation and/or clipping. More recently,
endoscopic placement of covered esophageal SEMS across the
transmural puncture site to tamponade bleeding has been
described.39,40 The SEMS diameter depends on the degree of dilation
(if any) of the transmural entry site. One or more side-by-side,
covered, 10-mm biliary stents and large diameter (esophageal
stents) can also be used.41 In the event of failed endoscopic therapy,
embolization is effective for arterial bleeding.21 Surgical therapymay
be necessary in some cases.41g; (B) hemostasis achieved with endoscopic clips.
Fig. 6. (A) Delayed post-polypectomy cecal bleeding with visible vessel (arrow) next to appendiceal oriﬁce (asterisk). (B) Bipolar coagulation of visible vessel following failed
attempt at clip placement (asterisk) due to indurated ulcer base. (C) Obliteration of visible vessel following bipolar coagulation (arrow).
Fig. 7. Persistent intra-procedural post-sphincterotomy bleeding. (A) Endoclip is opened; (B) after clip is applied, bleeding persists; (C) 7F bipolar cautery probe being brought into
visual ﬁeld with elevator of duodenoscope; (D) hemostasis achieved.
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Fig. 8. Bleeding related to PEG-induced ulcer.
Gastrointestinal Intervention 2012 1(1), 43–52 51Colonoscopy-induced barotrauma is characterized by several
linearmucosal breaks, particularly in the right colon, thatmay result
in blood pooling in the colonic lumen. No speciﬁc treatment is
required aside from decompressing the colon during endoscope
withdrawal.42
Initial APC of a large spidery vascular ectasia may result in brisk
bleeding, and further APC applications may be ineffective as coag-
ulum formation involves primarily accumulating blood rather than
the underlying vascular lesion. Before APC, injection of a small
amount of dilute epinephrine close to the center of the vascular
ectasia can signiﬁcantly constrict the size of the lesion and lessen
the risk of signiﬁcant bleeding during APC.
Conclusions
Intra-procedural or delayed bleeding after endoscopic therapy is
not uncommon. Procedure-related bleeding can be severe and
a source of signiﬁcant morbidity. In addition to hemodynamic
support, most procedure-related bleeding can be managed with
a variety of endoscopic hemostatic techniques. The selection of
a particular technique(s) is dependent on lesion characteristics and
location, device availability, and operator preference. Angiographic
and/or surgical interventions are required when endoscopic therapy
is not feasible or has failed.
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